Should You Buy Lemonade (LMND) While It's Below $65?

Lemonade (NYSE: LMND), the online insurer that uses AI chatbots to onboard customers and process claims, went public at $29 per share in July 2020. Today, its stock trades at about $55 -- yet it's still below Wall Street's median price target of $65. Should you buy Lemonade's stock before it hits that price? Let's review its business model and growth rates to make a decision.Image source: Getty Images.Lemonade's digital-first approach attracted many younger and first-time insurance buyers who were intimidated by the byzantine process of buying insurance. It initially offered only homeowners and renters insurance, but expanded into the term life, pet health, and auto insurance (via its acquisition of Metromile) markets after its public debut.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool